Moderna Vaccine: Approved vaccination sites for phase 2 of COVID vaccination exercise in Lagos State

Citizens; 18 years and above who have not received any COVID vaccine may proceed to register or enrol for the MODERNA vaccine via the NPHCDA E-Registration portal: https://nphcda.vaccination.gov.ng/

EXTRA INFORMATION

Citizens; 18 years and above who have not received any COVID vaccine may proceed to register or enrol for the MODERNA vaccine via the NPHCDA E-Registration portal: https://nphcda.vaccination.gov.ng/

👉🏽Successful enrollees should then proceed to any of the 183 vaccination sites picked at the point of registration at the time scheduled to get the first dose of vaccine.

Eligible Persons are advised to Pre-register on the NPHCDA E-Registration portal before visiting the Vaccination sites. This is *MANDATORY* .

Kindly note: *ONLY* pre-registered persons should visit the vaccination sites as scheduled.

The decision to get vaccinated is yours to make.

MODERNA Vaccine is Safe, Effective and Free.

No photo description available.
No photo description available.No photo description available.No photo description available.No photo description available.No photo description available.No photo description available.May be an image of text that says 'LAGOS STATE GOVERNMENT Ministry of Health LIST OF FACILITIES FOR PHASE 2 COVID VACCINATION Address LGAs Wards Surulere Facility Airways Surulere Airways PHC Muniru Baruwa Surulere 39/47, Airways Road, ljeshatedo Anjorin PHC Aralile 10/12, Anjorin Str, Off Lawanson Road Itire @ProfAkinAbayomi Femi Gbajabiamila PHC profakinabayomi Iyun Rd, Behind Salvation Army Pry School, Surulere ProfAkin Abayomi Prof.Akin Abayomi @LSMOH @lagoshealth'
No photo description available.

Get Vaccinated!

Protect yourself, Protect your loved ones, Protect your Community!

Total
0
Shares
Related Posts
Read More

FBNHoldings Wows the Market with 2023 H1 Earnings Blowout

FBNHoldings (FBNH), the parent company of Nigeria’s pioneer Bank, First Bank of Nigeria Limited published stellar results, confounding analysts, and exciting investors. Equally as amazing as the spectacular results, which saw earnings per share surge by 234% to N5.19 was the fact that the banking behemoth was able to eke out this profit in a financially hostile policy environment where bank earnings have been squeezed. The Bank’s holding company has also been a subject of shareholder squabbles, which ordinarily should be a distraction to the management and a drag on profitability. But in spite of these challenges, the outstanding results are a testimony to the depth of its management and its capacity to execute a robust strategy.